NIDDK in vivo efficacy of Fc-bispecifics study · FederalPipeline
NIDDK in vivo efficacy of Fc-bispecifics study
Presolicitation from National Institutes of Health, solicitation 75N98026Q00898TACONICBIOSCIENCESINC. Responses due Aug 6, 2026. NAICS 112990, No Set aside used. Listed on SAM.gov.